secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspira Women's Health Inc. (AWHL)
CIK:        0000926617
Form:       8-K
Filed at:   2023-05-16T23:59:59+00:00
Accession:  0000926617-23-000050
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aspira Women's Health appoints Torsten Hombeck as CFO, effective June 15, 2023
------------------------------------------------------------------------------

- Torsten Hombeck, Ph.D., named CFO; previously CFO of Akari Therapeutics.
- Annual base salary of $325,000 with bonus eligibility up to 50% of base.
- Initial stock option grant of 13,333 shares, vesting 33.3% annually over 3 years.
- Severance: 6 months base salary and COBRA if terminated without cause or resigns for good reason.
- Subject to 12-month non-compete and non-solicitation covenants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/926617/000092661723000050/0000926617-23-000050-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/926617/000092661723000050/awh-20230516x8k.htm
  HTML page:      https://secwatch.observer/filing/0000926617-23-000050

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer